Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Liver Cancer Market, and What Factors Will Drive It?

The size of the liver cancer market has experienced quick expansion in recent periods. The market, which is expected to surge from $2.94 billion in 2024 to $3.34 billion in 2025, has a predicted compound annual growth rate (CAGR) of 13.6%. The growth over the historic period can trace its roots to increased incidences of liver cancer globally, escalating rates of Hepatitis B and C infections, an increase in cases of non-alcoholic fatty liver disease, government policies encouraging early detection, and heightened consciousness about the health of the liver.

The market size for liver cancer is projected to experience a significant surge in the coming years, expanding to$5.62 billion by 2029 with a compound annual growth rate (CAGR) of 13.9%. This growth over the forecast period is linked to various factors such as an aging population, larger expenditure on healthcare, increased preference for less invasive treatments, growth of specialized clinics, and a surge in medical tourism. The forecast period also sees major trends, including progress in diagnostic technologies, the inception of targeted therapies, the combination therapy introduction, technological progress in surgical procedures, and improvements in radiotherapy techniques.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22039&type=smp

What Are the Core Growth Drivers Propelling the Liver Cancer Market Forward?

The escalation in the usage of alcohol is anticipated to fuel the progression of the liver cancer market. The term alcohol consumption relates to the ingestion of alcoholic drinks, often quantified by volume and regularity. The increasing trend of alcohol consumption can be linked to its perceived benefits in reducing everyday stress, enhancing social interactions at events, and promoting relaxation moments. Overexposure to alcohol, largely due to its widespread promotion in media and greater accessibility, can result in liver cirrhosis, inflammation, and harm to DNA, thereby augmenting the chance of liver cancer by initiating irregular cell development. To illustrate, statistics from the National Drugs Library, a data compiling organization from Ireland, revealed in March 2023 that the mean alcohol consumption for people above 15 years of age had enlarged to 10.2 liters of pure alcohol per person in 2022. This represents a rise of 7.6% from the previous year. Consequently, the upsurge in alcohol usage stimulates the liver cancer market.

What Segment Types Define the Liver Cancer Market Structure?

The liver cancermarket covered in this report is segmented –

1) By Type: Hepatoblastoma; Intrahepatic Cholangiocarcinoma; Hepatocellular Carcinoma; Fibrolamellar Carcinoma

2) By Stage Of Liver Cancer: Early Stage; Intermediate Stage; Advanced Stage

3) By Treatment: Targeted Therapy; Radiation Therapy; Surgery; Chemotherapy; Immunotherapy

4) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Cancer Research Institutes

Subsegments:

1) By Hepatoblastoma: Epithelial Hepatoblastoma; Mixed Epithelial and Mesenchymal Hepatoblastoma

2) By Intrahepatic Cholangiocarcinoma: Mass-forming Cholangiocarcinoma; Periductal Infiltrating Cholangiocarcinoma; Intraductal Growing Cholangiocarcinoma

3) By Hepatocellular Carcinoma: Fibrolamellar Hepatocellular Carcinoma; Conventional Hepatocellular Carcinoma; Scirrhous Hepatocellular Carcinoma; Clear Cell Hepatocellular Carcinoma; Lymphoepithelioma-like Hepatocellular Carcinoma

4) By Fibrolamellar Carcinoma: Classic Fibrolamellar Carcinoma; Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22039&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Liver Cancer Market?

North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theLiver Cancer Industry Evolution?

Leading businesses in the liver cancer market are concentrating on the invention of cutting-edge therapy devices that deliver transcatheter arterial chemoembolization (TACE), with the goal of improving treatment accuracy, enhancing patient outcomes, and minimizing adverse reactions. TACE is a less invasive procedure which administers chemotherapy right into the liver tumor and blocks its blood flow for better treatment efficacy. For instance, Terumo Corporation, a medical technology organization based in Japan, in November 2023, introduced Occlusafe and LifePearl, two avant-garde treatment devices for liver cancer management. These devices aim to improve the handling of liver cancer, especially hepatocellular carcinoma (HCC), the most prevalent form of primary liver cancer in India with more than 20,000 fresh cases reported every year. Occlusafe, a component of an advanced intervention named Balloon-TACE (B-TACE), enriches the accuracy and effectiveness of TACE by utilizing a balloon to occlude blood circulation during the procedure. LifePearl are polyethylene glycol (PEG) embolization microspheres that are capable of carrying chemotherapeutic agents.

View the full report here:

https://www.thebusinessresearchcompany.com/report/liver-cancer-global-market-report

What Is the Definition of the Liver Cancer Market?

Liver cancer is a malignant disease that originates in the liver cells, primarily hepatocytes, and can spread to other organs. It is associated with risk factors such as chronic hepatitis B and C infections, cirrhosis, excessive alcohol consumption, and non-alcoholic fatty liver disease (NAFLD). The disease is often diagnosed at advanced stages, making early detection and treatment crucial for improving survival rates.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22039

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model